Global financial markets plunged on Thursday, April 2, 2026, following a prime-time address by U.S. President Donald Trump in which he vowed to escalate military action against Iran, reigniting fears of a prolonged and widening conflict in the Middle East. The announcement triggered a sharp sell-off in equity futures and a dramatic spike in oil prices.
President Trump declared that the United States would strike Iran "extremely hard" over the next two to three weeks, with the stated goal of preventing Tehran from obtaining a nuclear weapon. He ominously added, "We’re going to bring them back to the Stone Ages where they belong." This statement directly contradicted earlier social media posts from Trump claiming Iran's new regime president had requested a ceasefire, a claim swiftly denied by Iran's Foreign Ministry.
The immediate market reaction was severe. Brent crude oil futures surged more than 6-7%, briefly surpassing $110 per barrel before settling around $107.98. This marks a continuation of a staggering trend, as Brent had already gained more than 60% in March alone—its largest monthly increase since records began in the 1980s—following initial U.S.-Israel strikes on February 28 and subsequent Iranian retaliation.
Equity markets globally reflected the risk-off sentiment. In Europe, Euro Stoxx 50 futures fell 2%, DAX futures lost 1.9%, and FTSE 100 futures dropped 0.9%. In the United States, futures for the S&P 500, Dow Jones Industrial Average, and Nasdaq 100 all fell more than 0.8% following the speech.
A critical uncertainty driving the oil price surge is the status of the Strait of Hormuz, a 21-mile-wide chokepoint through which about one-fifth of the world's oil passes. Trump stated that other nations should "take the lead" on reopening the strait, suggesting it could "open up naturally," but provided no clear timeline for the restoration of normal oil flows. This disruption poses a significant threat to global energy supply.
Adding further pressure to market sentiment, reports indicated the Trump administration is moving to impose tariffs on pharmaceutical companies that refuse lower drug prices in the U.S., with levies potentially introduced within weeks. Analysts identified three key variables for future market direction: the trajectory of the Iran conflict, the scale and duration of oil supply disruptions, and the timing of the proposed pharmaceutical tariffs.
